M. Donato

PREVALENCE OF ANTIBODIES TO HEPATITIS C VIRUS IN ITALIAN PATIENTS WITH HEPATOCELLULAR CARCINOMA

M. Houghton, M. Colombo, Q. Choo, 1989, The Lancet.

Asymptomatic hepatitis G virus infection in blood donors

A. Zanella, G. Sirchia, D. Prati, 1997, Transfusion.

A prospective, randomized trial comparing lymphoblastoid to recombinant interferon alfa 2a as therapy for chronic hepatitis C

J. Wilber, M. Colombo, M. F. Donato, 1996, Hepatology.

Sustained response to interferon-alpha2a monotherapy of young blood donors with minimal-to-mild chronic hepatitis C. The Donor Surveillance Study Group.

A. Zanella, G. Sirchia, D. Prati, 2000, Journal of viral hepatitis.

Increased expression of vascular endothelial growth factor in small hepatocellular carcinoma

M. Colombo, P. Lampertico, F. Bertolini, 2007, Journal of viral hepatitis.

Progressive hepatic fibrosis in healthy carriers of hepatitis C virus with a transaminase breakthrough

F. De Filippi, M. Colombo, M. F. Donato, 2002, Journal of viral hepatitis.

Serum Autoantibodies Against Cytochrome P450 2E1 (CYP2E1) Predict Severity of Necroinflammation of Recurrent Hepatitis C

C. Rigamonti, M. Vidali, M. Donato, 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Interferon‐α suppresses liver cell proliferation in patients with chronic hepatitis C virus infection

P. Marcellin, A. Morabito, C. Degott, 2005, Journal of viral hepatitis.

Hepatocellular carcinoma in Italian patients with cirrhosis.

M. Colombo, R. de Franchis, V. Di Carlo, 1991, The New England journal of medicine.

Increased expression of vascular endothelial growth factor in small hepatocellular carcinoma.

M. Colombo, P. Lampertico, F. Bertolini, 2007, Journal of viral hepatitis.